Global Research Antibodies Market is valued USD 2.64 billion in 2016 is anticipated to grow USD XXX billion with the compounded annual growth of 6.30% over the forecast period 2018-2025.
New York 18 Aug 2018, As per the new research study conducted by Bizwit Research & Consulting, Global Research Antibodies Market industry is poised to raise USD 4.6 billion by 2025. The antibodies market has also been segmented on the basis of type, source, and research area. Based on type, the research antibodies market is segmented into primary antibodies and secondary antibodies. In 2016, the primary antibodies is expected to dominate the market due to its high adoption in numerous types of assay formats, including western blotting, ELISA, immunoprecipitation, and IHC. These antibodies provide high specificity, sensitivity, and affinity; which further drives their high adoption. On the basis of source, the antibodies market has been segmented into mice, rabbit, and other animals (chickens, goats, rats, guinea pigs, hamsters, and sheep). The mice segment dominated the market in 2016.
To view the summary or to request a sample copy of this report, please click the link mentioned below:
Global Research Antibodies Market Size study, by Product (Reagents, Antibodies), by Technology, by Application (Proteomics, Drug Development, Genomics), by End User and by Regional Forecasts 2018-2025
The industry is seeming to be fairly competitive. Some of the leading market players include Merck Group, Abcam PLC, Becton, Dickinson and Company, Cell Signaling Technology, Inc, Bio-Rad Laboratories, Inc. , Lonza , Genscript , Biolegend, Inc., Danaher Corporation, Thermo Fisher Scientific Inc and so on. The fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.
Key findings of the study:
- Europe, Asia-Pacific, North America, Latin America, and the Middle East & Africa. North America holds the largest share of this market.
- The Asia Pacific region will be the highest growing segment with respect to geographical segmentation, the region is likely to grow by XX% CAGR over the forecast period 2018-2025
Bizwit Research & Consulting LLP has considered following segments for the study:
- Western Blotting
- Flow Cytometry
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Drug Development
By End User:
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
- North America
- Asia Pacific
- Latin America
- Rest of the World